Brief: Adverum Biotechnologies Board Decreased Total Number Of Authorized Directors From Nine To Seven Directors
21/12/2021 13:17
Dec 21 (Reuters) - Adverum Biotechnologies Inc ADVM.O :
* ADVERUM BIOTECHNOLOGIES INC - ON DEC 16, 2021, BOARD
DECREASED
TOTAL NUMBER OF AUTHORIZED DIRECTORS FROM NINE TO SEVEN
DIRECTORS
* ADVERUM BIOTECHNOLOGIES INC - BOARD IS ACTIVELY PURSUING
ADDITION OF TWO NEW DIRECTORS WITH FOCUS ON ADDING FURTHER
EXPERTISE IN GENE THERAPY
Further company coverage: ADVM.O
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)